The present invention relates to a pharmaceutical composition or a kit comprising, a first substance capable of raising intracellular cAMP levels, and a second substance capable of modulating intracellular calcium concentration.
Likewise, the present invention relates to methods of treating patients suffering from autism spectrum disorder (ASD) phenotype 1 by administering an effective amount of a substance capable of raising intracellular cAMP levels and, optionally, an effective amount of a substance capable of modulating intracellular calcium concentration.
本发明涉及一种药物组合物或试剂盒,其中包括能够提高细胞内c
AMP水平的第一种物质和能够调节细胞内
钙浓度的第二种物质。
同样,本发明涉及治疗自闭症谱系障碍(A
SD)表型1患者的方法,即施用有效量的能够提高细胞内c
AMP水平的物质,以及可选地施用有效量的能够调节细胞内
钙浓度的物质。